Watch our videos
on YouTube
Follow us on
Join us on
Choose your
See how a cochlear implant works: Cochlear Implant


Cochlear Implants

Device for severe to profound hearing loss.

A cochlear implant system is a medical option for individuals with severe to profound sensorineural hearing loss. For individuals with this type of hearing loss, hearing aids provide little or no benefit.
Cochlear Implant System for Hearing Loss
Users choose the Cochlear Implant System because it offers a superior hearing experience in real-life situations. The system contains features optimised for the appreciation of music and for listening in challenging situations. The design of the cochlear implant (CI) makes the system suitable for children as well as for adults and is optimized for minimally invasive surgical techniques, thus reducing surgery time. Users can choose between a single-unit or a behind-the-ear audio processor. The audio processors come in a variety of different colors.
At the hearLIFE Clinic we believe that it is essential to leave the neural tissues of the cochlea intact following surgery. This applies to all cochlear implant patients and especially to young children who may face multiple implantations in their lifetime. It is likely that any future invention, may it be device, biological, or pharmaceutical in nature, will be more successful in a cochlea that has suffered minimal trauma through reduced insertion force.

The Cochlear Implant electrode arrays have an exclusive design for preserving the integrity of delicate structures in the cochlea. These atraumatic electrode arrays are available in many different designs, shapes and lengths to fit a variety of unique cochlea anatomies. Your hearLIFE Clinic otology specialist will choose the appropriate solution for you.


The Cochlear Implant System

  1. Calculated from Haumann et al. (2010) using the psychometric function from Schmidt et al. (1997).
  2. Brough et al. (2010) Speech discrimination scores using the latest generation of speech processors, CII, 11(S2): 119-24.
© 2019 MED-EL